Key result
Low CALLY index is linked to ~4.2-fold higher 1-year major cardiovascular events in non-diabetic multivessel NSTEMI.
Why the study?
The prognostic value of the triglyceride-glucose (TyG) and C-reactive protein-albumin-lymphocyte (CALLY) indices in non-diabetic patients with NSTEMI and multivessel disease, and whether this value depends on revascularization status, was unknown.
Do the CALLY and triglyceride-glucose (TyG) indices predict one-year major adverse cardiovascular events (MACE) and provide incremental prognostic value over the GRACE score in non-diabetic patients with NSTEMI and multivessel disease across complete and incomplete revascularization strategies?
Cohort (n=1,424)
No
Do the CALLY and triglyceride-glucose (TyG) indices predict one-year major adverse cardiovascular events (MACE) and provide incremental prognostic value over the GRACE score in non-diabetic patients with NSTEMI and multivessel disease across complete and incomplete revascularization strategies?
In non-diabetic patients with NSTEMI and multivessel disease, the CALLY index strongly predicts 1-year MACE regardless of revascularization completeness, whereas the TyG index predicts risk primarily after complete revascularization, with both indices providing incremental discriminative value beyond the GRACE score.
Answers are grounded in this paper and cite their sources.
May enhance GRACE-based stratification in non-diabetic NSTEMI; hypothesis-generating pending prospective validation.
Background The triglyceride-glucose (TyG) and C-reactive protein-albumin-lymphocyte (CALLY) indices reflect metabolic and inflammatory-nutritional risk, but their prognostic value in non-diabetic patients with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease, and whether this value depends on revascularization status, is unknown. We examined the association of both indices with one-year major adverse cardiovascular events (MACE) and their incremental value over the GRACE score. Methods We retrospectively studied 1,424 non-diabetic NSTEMI patients with multivessel disease, of whom 738 (51.8%) underwent complete revascularization (CR) and 686 (48.2%) incomplete revascularization (ICR). The prognostic value of each index was assessed by ROC analysis, Kaplan–Meier survival, and Cox regression, and their incremental value over GRACE by reclassification metrics. Results MACE occurred in 174 patients (12.2%) over one year. The CALLY index predicted risk in both groups, with an approximately fourfold risk in the lowest versus the highest tertile (adjusted HR 4.23), and its effect did not vary with revascularization status (interaction p = 0.40). The prognostic association of TyG appeared to differ by revascularization status: it was significant after CR (HR 2.66) but not after ICR (HR 1.42), although the interaction did not reach significance ( p = 0.070). Adding both indices improved discrimination beyond GRACE (C-index 0.694 to 0.743; continuous net reclassification improvement 0.259 for CALLY). Conclusion In non-diabetic NSTEMI with multivessel disease, the CALLY index is a revascularization-independent prognostic marker, whereas the prognostic value of the TyG index appeared mainly in patients with complete revascularization, suggesting a possible trend toward effect modification that requires confirmation. Interpreted in the context of revascularization, these two readily available indices may refine risk stratification beyond the GRACE score.
No takes yet. Share an insight, caveat, or question.
Karayakalı et al. (2026) conducted a cohort in Non-diabetic non-ST-elevation myocardial infarction (NSTEMI) with multivessel disease (n=1,424). Lowest CALLY index tertile (0.02-0.93) vs. Highest CALLY index tertile (2.05-31.04) was evaluated on 1-year major adverse cardiovascular events (MACE: composite of cardiovascular or cerebrovascular death, non-fatal myocardial infarction, non-fatal stroke, and unplanned target-vessel revascularization) (HR 4.23, 95% CI 2.57-6.99, p=<0.001). A low CALLY index independently predicted one-year major cardiovascular events regardless of revascularization completeness in non-diabetic NSTEMI with multivessel disease.
Synapse has enriched 10 related papers. Consider them for comparative context: